Daniel

Daniel

Daniel

From Daniel

Cooley

Cooley Advised Investor Syndicate on $2.25 Billion Acquisition of HistoSonics

Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority

Read Articles
USPTO

USPTO Director Refuses iRhythm’s Bid to Review Decision Scrapping IPRs Based on ‘Settled Expectations’

Arguing that Welch Allyn allowed its patents to lie dormant between 2012 and 2024, iRhythm filed a petition for Director

Read Articles
pharma

US President Donald Trump threatens pharma to deliver on Most Favored Nation drug pricing

The directive aims to reduce drug prices by 30 to 80 percent in the country

Read Articles
Eszter-Török-Rodica-Manea

CMS Advised Bonafarm Group on Acquisition of Market-leading Dairy Business FrieslandCampina Romania

CMS advised Bonafarm Group, one of Hungary’s largest vertically integrated agri-food businesses, on its acquisition of Royal

Read Articles
Bored-Ape

Bored Ape Maker’s $8.8 Million Win in NFT Trademark Case Overturned by US Appeals Court

A US appeals court confirmed that NFTs qualify as “goods” under trademark law — a key development for the NFT industry.

Read Articles
Trademark

Sunkist Wins US Court Appeal to Block ‘Kist’ Trademark

IDI, based in Detroit, bought the rights to ‘Kist’, a vintage Midwestern soda brand, in 2009 and has marketed it in glass

Read Articles
CAFC

TTAB Dismissal of Sunkist’s Opposition Reversed by CAFC

Sunkist submitted sixteen registrations during the opposition, but the TTAB dismissed the case finding no likelihood of confusion.

Read Articles
Josh-Hawley

Congress Must Step In to Fix AI Companies’ Mass Theft of Copyrighted Works: Senator Josh Hawley

AI companies are training their models on allegedly stolen materials and have copied enough works to fill 22 Libraries

Read Articles
Christopher-DeCresce

Freshfields Advised Underwriters On IPO Of Globa Terra Acquisition Corporation

Freshfields advised underwriters led by D. Boral Capital LLC on the IPO of Globa Terra Acquisition Corporation, involving 17,499,550 units including the full overallotment option.

Read Articles
Sun-Pharma

Sun Pharma Launches Anti-Baldness Drug Leqselvi In The US

The drug can generate up to $400 million in sales by FY30 with peak sales potential of $900 million, and boost growth in

Read Articles
Share it